Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the association of hormonal implant with gestrinone in cardiovascular health outcomes in young women.
After being informed about the study, volunteers will be screened in accordance with eligibility criteria. Eligible volunteers will be invited to appear to the research institute and participate in the study. All volunteers giving the written informed consent will perform all assessments in the same day at their visit.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Gestrinone implant | Young women using hormonal implant with gestrinone. |
| |
| Control group | Young women who never used hormonal implant with gestrinone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hormonal implant | Other | History of at least 1 hormonal implant with gestrinone in the last 6 months, applied by the participant's private doctor. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Endothelial function | Brachial artery endothelial function assessed by flow-mediated dilation (FMD). | Day 1. |
| Measure | Description | Time Frame |
|---|---|---|
| Arterial stiffness | Carotid-femoral pulse wave velocity (PWV). | Day 1. |
| Heart rate | Heart rate assessed together with the cardiac autonomic modulation procedure. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Young women.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Luciana Diniz Nagem Janot de Matos, MD, PhD | Medical Referencee - Rehabilitation Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Israelita Albert Einstein | São Paulo | São Paulo | 05652-900 | Brazil |
There will be no individual participant data (IPD) shared.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D035061 | Control Groups |
| ID | Term |
|---|---|
| D015340 | Epidemiologic Research Design |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D012107 | Research Design |
Not provided
Not provided
Not provided
Not provided
Not provided
| Control group | Other | Young women who never used any hormonal implant. |
|
| Day 1. |
| Blood pressure | Systolic, diastolic and mean blood pressure will be evaluated by auscultatory method. | Day 1. |
| Cardiac autonomic modulation | Heart rate variability (HRV) analyzed in the time domain, frequency domain, and non-linear method. | Day 1. |
| Lipid profile | Total cholesterol, non-HDL cholesterol, low-density lipoprotein (LDL-c), high-density lipoprotein (HDL-c), and triglycerides will be analyzed by laboratory exams. | Day 1. |
| Glycemia | Glycemia will be analyzed by laboratory exams. | Day 1. |
| Ultra-sensitive C-reactive protein (us-CRP) | us-CRP will be analyzed by laboratory exams. | Day 1. |
| Hemoglobin | Hemoglobin will be analyzed by laboratory exams. | Day 1. |
| Hematocrit | Hematocrit will be analyzed by laboratory exams. | Day 1. |
| Progesterone | Progesterone will be analyzed by immunoassay technique. | Day 1. |
| 17-alpha-hydroxyprogesterone (17-OHP) | 17-OHP will be analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). | Day 1. |
| Dehydroepiandrosterone (DHEA) | DHEA will be analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). | Day 1. |
| Androstenedione | Androstenedione will be analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). | Day 1. |
| Free testosterone | Free testosterone will be calculated considering total testosterone and SHBG. | Day 1. |
| Total testosterone | Total testosterone will be analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). | Day 1. |
| Estradiol | Estradiol will be analyzed by immunoassay technique. | Day 1. |
| Follicle-stimulating hormone (FSH) | FSH will be analyzed by immunoassay technique. | Day 1. |
| Luteinizing hormone (LH) | LH will be analyzed by immunoassay technique. | Day 1. |
| Sex hormone-binding globulin (SHBG) | SHBG will be analyzed by immunoassay technique. | Day 1. |
| Muscular strength | It will be assessed by handgrip. | Day 1. |
| D008722 | Methods |